These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31861339)
1. Recent Progress in Mitochondria-Targeted Drug and Drug-Free Agents for Cancer Therapy. Jeena MT; Kim S; Jin S; Ryu JH Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861339 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment. Battogtokh G; Cho YY; Lee JY; Lee HS; Kang HC Front Pharmacol; 2018; 9():922. PubMed ID: 30174604 [TBL] [Abstract][Full Text] [Related]
4. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria. Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrion-Targeting Peptides and Peptidomimetics: Recent Progress and Design Principles. Kim S; Nam HY; Lee J; Seo J Biochemistry; 2020 Jan; 59(3):270-284. PubMed ID: 31696703 [TBL] [Abstract][Full Text] [Related]
6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Processes in Targeted Cancer Therapy. Krejčíř R; Valík D; Vojtěšek B Klin Onkol; 2018; 31(Suppl 2):14-20. PubMed ID: 31023019 [TBL] [Abstract][Full Text] [Related]
8. Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents. Ralph SJ; Low P; Dong L; Lawen A; Neuzil J Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):327-46. PubMed ID: 18221044 [TBL] [Abstract][Full Text] [Related]
9. Mitochondria as therapeutic targets for the treatment of malignant disease. Fulda S; Kroemer G Antioxid Redox Signal; 2011 Dec; 15(12):2937-49. PubMed ID: 21644835 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria. Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies. Skoda J; Borankova K; Jansson PJ; Huang ML; Veselska R; Richardson DR Pharmacol Res; 2019 Jan; 139():298-313. PubMed ID: 30453033 [TBL] [Abstract][Full Text] [Related]
17. Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives. Battogtokh G; Choi YS; Kang DS; Park SJ; Shim MS; Huh KM; Cho YY; Lee JY; Lee HS; Kang HC Acta Pharm Sin B; 2018 Oct; 8(6):862-880. PubMed ID: 30505656 [TBL] [Abstract][Full Text] [Related]
18. Mitochondria-Targeted Self-Assembly of Peptide-Based Nanomaterials. Luo Z; Gao Y; Duan Z; Yi Y; Wang H Front Bioeng Biotechnol; 2021; 9():782234. PubMed ID: 34900970 [TBL] [Abstract][Full Text] [Related]
19. Targeting mitochondria in cancer: current concepts and immunotherapy approaches. Pustylnikov S; Costabile F; Beghi S; Facciabene A Transl Res; 2018 Dec; 202():35-51. PubMed ID: 30144423 [TBL] [Abstract][Full Text] [Related]
20. A multi-functional organelle mitochondrion is involved in cell death, proliferation and disease. Ohta S Curr Med Chem; 2003 Dec; 10(23):2485-94. PubMed ID: 14529464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]